Life technologies corporation:1107072 [19-000001]

Ended Purchase Order Awarded Last action

Contract number
75N91019P00094
Awardee
Awarding agency
Obligated
$18,763

Award facts

Contract value 100% obligated
$18,763.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · The purpose of this modification is to DE-obligate funds from FY2019 expiring lines. -$1,483
Original award $20,246

About this award

The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $18,763.40 on December 28, 2018, with completion due January 31, 2024. The order represents a de-obligation of expiring fiscal year 2019 funds. Place of performance is Bethesda, Maryland. The contract carries firm fixed pricing with no small business set-aside.

Quick answers

Who was awarded contract 75N91019P00094?

75N91019P00094 was awarded to Life Technologies Corporation by National Cancer Institute (National Institutes of Health) on December 28, 2018.

How much is contract 75N91019P00094 worth?

The government has obligated $18,763 on 75N91019P00094.

Was contract 75N91019P00094 competed?

The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award